Mitchell E. Taub
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mitchell E. Taub has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Ting Wang
Department of Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, USA
4 shared publications - Aaron M. Teitelbaum
Department of Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, USA
2 shared publications - Hamid Samareh Afsari
Department of Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, USA
2 shared publications - Pallabi Mitra
Department of Clinical Pharmacology & Nonclinical Safety Sciences, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut
2 shared publications - Steven Anderlot
Department of Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, USA
2 shared publications Ting Wang
2 shared publications
Latest Publications
- 21 October 2026
- Published by Elsevier in Drug Metabolism and Pharmacokinetics
- Vol. 71
UGT1A1 isoform-selective allosteric inhibition by dirithromycin
- 21 October 2026
- Published by Elsevier in Drug Metabolism and Pharmacokinetics
- Vol. 71
UGT1A1 isoform-selective allosteric inhibition by dirithromycin
- Open Access
- 8 September 2026
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 54 (10)
Interindividual variability in hepatic hydrolytic enzymes: Effects of age, sex, and race on the abundance of drug-metabolizing hydrolases
- 8 September 2026
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 54 (10)
Open AccessInterindividual variability in hepatic hydrolytic enzymes: Effects of age, sex, and race on the abundance of drug-metabolizing hydrolases
- Open Access
- 26 December 2025
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 54 (2) , 100228
Transporter-transporter interplay determines the renal-predominant elimination of the O-glucuronide metabolite (BI 689875) of vicadrostat in humans
- 26 December 2025
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 54 (2) , 100228
Open AccessTransporter-transporter interplay determines the renal-predominant elimination of the O-glucuronide metabolite (BI 689875) of vicadrostat in humans
- 8 October 2025
- Published by Springer Nature in The AAPS Journal
- Vol. 27 (6) , 1
Correction: One-step Immobilization of Human α-1-acid Glycoprotein on Magnetic Beads: A Rapid Method for Small Molecule hAGP Binding Study
- 8 October 2025
- Published by Springer Nature in The AAPS Journal
- Vol. 27 (6) , 1
Correction: One-step Immobilization of Human α-1-acid Glycoprotein on Magnetic Beads: A Rapid Method for Small Molecule hAGP Binding Study
- 18 September 2025
- Published by Springer Nature in The AAPS Journal
- Vol. 27 (6) , 1-12
One-step Immobilization of Human α-1-acid Glycoprotein on Magnetic Beads: A Rapid Method for Small Molecule hAGP Binding Study
Human α-1-acid glycoprotein (hAGP) immobilized directly on NHS ester (N-hydroxysuccinimide) activated magnetic beads (hAGP-beads) was developed as a n
- 18 September 2025
- Published by Springer Nature in The AAPS Journal
- Vol. 27 (6) , 1-12
One-step Immobilization of Human α-1-acid Glycoprotein on Magnetic Beads: A Rapid Method for Small Molecule hAGP Binding Study
Human α-1-acid glycoprotein (hAGP) immobilized directly on NHS ester (N-hydroxysuccinimide) activated magnetic beads (hAGP-beads) was developed as a n